Trupanion Jumps on Q2 Beat and Buyback as Volume Spikes 4.7x
TRUP volume surged 4.7x average on a Q2 earnings beat and buyback news, but weak ROE, 127% debt ratio, and recent insider selling temper the low 6.5x P/E story.
signal:TRUP:2026-08-06 Trupanion Jumps on Q2 Beat and Buyback as Volume Spikes 4.7x
Trading volume in Trupanion (TRUP) surged to 4.7x its 20-day average after the pet insurer posted a Q2 EPS of $0.16 versus the $0.1156 consensus — a 38.4% earnings surprise — while also announcing a new share buyback program and guiding Q3 revenue to $399 million-$405 million, above the $398.218 million Street estimate. The convergence of an earnings beat, a capital-return signal, and raised forward guidance on a stock trading at just 6.5x forward earnings is the combination now drawing fresh attention to the name.
For a company still carrying thin profitability metrics, that kind of trifecta landing on the same day is unusual enough to warrant a closer look at whether the re-rating has more room to run or whether the move is already pricing in the good news.
Key Facts
| Stock name | TRUP |
|---|---|
| Ticker | TRUP |
| Market | NASDAQ |
| Sector | Unclassified |
| Volume (x average) | 4.7x |
| Signal price | $28.16 |
Trupanion, Inc., together with its subsidiaries, provides medical insurance for cats and dogs on a subscription basis across the United States, Canada, and Continental Europe, serving pet owners and veterinarians through its Subscription Business and Other Business segments. Founded in 2000 and headquartered in Seattle, Washington, the company was originally incorporated as Vetinsurance International, Inc. before adopting the Trupanion name in 2013.
Recent Analyst Coverage
External analyst opinions (not investment advice): (2026-08-01)
| Strong Buy | 4 |
|---|---|
| Buy | 4 |
| Hold | 4 |
| Sell | 0 |
| Strong Sell | 0 |
Peer Companies
SAFT, XZO, UFCS, UVE, ASIC
Risk Factors
Beneath the low 6.5x forward earnings multiple sits a balance sheet that still needs to prove itself: return on equity of just 4.8% and a debt ratio of 127% point to weak capital efficiency, while an EV/EBITDA of 21.6x is far from cheap on an enterprise-value basis — a combination that fits the profile of a potential value trap where a depressed headline multiple masks structurally weak returns rather than a genuine bargain. Insider activity adds a note of caution as well: Form 4 filings show one open-market sale and no purchases in the past ten days, which is not a bullish signal even against an earnings beat.
The macro backdrop is a secondary but relevant headwind. The 10-year Treasury yield has climbed to 4.67%, up 0.13 percentage points over the past month in a rising-rate trend that tends to pressure names carrying an elevated EV/EBITDA multiple like this one, even if the low P/E offers some relative cushion. The dollar index (DXY) at 100.0, down 1.0% over the same period and trading sideways, is a more neutral factor for now, but broad risk appetite as measured by a VIX of 15.1 remains in a normal range rather than signaling either strong tailwind or stress.
Recent Disclosures
Recent News
- 2026-08-06 Trupanion, Inc. (TRUP) Q2 2026 Earnings Call Transcript
- 2026-08-05 Trupanion (NASDAQ:TRUP) Rises After Q2 Earnings Beat and Buyback Program Announcement
- 2026-08-05 Trupanion Sees Q3 Sales $399.000M-$405.000M vs $398.218M Est
Earnings Trend
| Fiscal Year | Revenue | Net Income |
|---|---|---|
| 2023 | $1,109M | - |
| 2024 | $1,286M | - |
| 2025 | $1,439M | - |
Trade Levels
| Signal price | $28.16 |
|---|---|
| Stop-loss | $25.34 (-10% from signal price) |
| First take-profit | $33.79 (+20% from signal price) |
| Trailing stop | 10% from peak |
| Invalidation | Close back below key support ($25.61) |
With shares trading near the $28.16 signal price, the setup to watch pairs a $33.79 first take-profit level (plus a 10% trailing stop from any subsequent peak) against a $25.34 stop-loss, and a thesis that would be considered invalidated on a close back below the $25.61 support level — a range worth monitoring as the market digests this week's earnings beat, buyback announcement, and raised guidance rather than a signal to chase the move today.